Nic Aldrich, VP of Marketing at OrthAlign, discusses recent milestones and future directions of its hand...
EpiBone advances its stem-cell-derived osteochondral graft toward US Phase 1/2b trials. Following a succ...
What does real-time Total Joints market intelligence look like? Every day, SmartTRAK analysts monitor Me...